Inter and intra observer reproducibility of the new Oxford CCD Scheimpflug camera

External factors in the development of cataract

AIMS

To provide an update on the risk factors for cataract development.

METHODS

Review of the literature.

RESULTS

Age and heredity are the most important risk factors associated with the different types of cataract. While the hereditary component is self-explanatory, increasing age serves as a surrogate for a number of potential external risk factors, the effect of which is cumulative. Identification of the risk factors that have a causal effect on cataract development may provide means for cataract prevention. There are only a few risk factors that satisfy the criteria for causal effect: smoking, which results in the increased risk of nuclear cataract, excessive UV-B exposure and diabetes that increase the risk of cortical cataract, and steroidal treatment, diabetes and ionising radiation that lead to the formation of posterior subcapsular opacity. The effect of medications on cataract development requires further study, since the effect of the diseases should be distinguished from that of treatment. 'Stop Smoking' and 'UV-B protection' campaigns are gaining momentum as preventative measures, while the attempts to actively prevent cataract with antioxidants have not been successful. Cataract research has been facilitated lately by improvements of precision and standardisation in measuring lens opacities. However, measurement precision on its own cannot give us a solution to this problem.

CONCLUSION

The major studies repeatedly measure the exposure to the traditional health hazards, while the missing parts in the equation are those risk factors that we do not know about and therefore do not measure. New approaches and new hypotheses are needed.

Agreement between Scheimpflug photography and A-scan ultrasonography in anterior segment ocular measurements in children

PURPOSE

The Scheimpflug principle, as a method of performing biometry on the anterior segment, has not been widely used in the clinical setting compared with ultrasonography. The purpose of this study was to examine the agreement in anterior chamber length and lens thickness measurements between A-scan ultrasonography and Scheimpflug photography.

METHODS

A total of 252 children aged between 6 and 12 years participated in this study. All subjects had instillation of cycloplegic eye drops before measurement. Scheimpflug photography and A-scan ultrasonography were performed in this sequence on the same day. The anterior segment length on the Scheimpflug images was taken as the axial corneal thickness added to the anterior chamber depth. A-scan ultrasonography was performed by placing the probe on the corneas after topical anesthesia. Differences were obtained by subtracting the A-scan ultrasonography measurements from the Scheimpflug measurements. Data were analyzed using difference vs. mean plots.

RESULTS

For anterior chamber length, the mean difference between the two methods was -0.03 +/- 0.16 mm, with 95% limits of agreement of -0.35 to +0.30 mm. However, Scheimpflug readings were greater than that of ultrasonography for smaller measurements, and the opposite was true for larger measurements. For lens thickness, the mean difference was -0.2 +/- 0.10 mm, with 95% limits of agreement of -0.40 to +0.00 mm. For the measurement of lens thickness, adding a correction factor of 0.2 mm to Scheimpflug's readings should replace that of A-scan readings reasonably well.

CONCLUSIONS

The readings obtained from these two methods of biometry must be used with the knowledge of the instruments. We discuss the possible reasons for the difference in readings obtained using these two instruments.

Genetic and environmental factors in age-related nuclear cataracts in monozygotic and dizygotic twins

BACKGROUND

Age-related cataracts are a major public health problem. The relative importance of genes and environment in the causation of nuclear cataracts, the most common form of age-related cataracts, is not known.

METHODS

We studied 506 pairs of female twins (226 monozygotic and 280 dizygotic) who were 50 to 79 years old (mean, 62). The amount of nuclear cataract in the right and left eyes was determined objectively by analysis of Scheimpflug lens photographs (yielding three measures) and subjectively with use of the Oxford Clinical Cataract Classification and Grading System (yielding one measure). All eight measures (four in each eye) were subsequently combined in one summary measure of nuclear cataract for each woman. A univariate maximum-likelihood model was used to estimate the variance of the genetic and environmental contributions to each of the measures.

RESULTS

The different measures of cataract formation were highly correlated (correlation coefficients, 0.71 to 0.94). The mean scores were similar for the right and left eyes and for monozygotic and dizygotic twins. Quantitative genetic modeling of each of the nuclear-cataract scores invariably resulted in a best-fitting model that involved additive genetic effects, unique environmental effects, and age. The common environmental and dominant genetic effects could be removed from the models without significant loss of fit. The overall heritability in the combined nuclear-cataract score (the proportion of the variance explained by genetic factors) was 48 percent (95 percent confidence interval, 42 to 54 percent); age accounted for 38 percent of the variance (95 percent confidence interval, 31 to 44 percent) and unique environmental effects for 14 percent (95 percent confidence interval, 12 to 18 percent).

CONCLUSIONS

Genetic effects are important even in such a clearly age-related disease as nuclear cataract, explaining almost 50 percent of the variation in the severity of this disease.

Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group

AIMS

A detailed assessment of ophthalmic effects of an HMG CoA reductase inhibitor, simvastatin, was performed.

METHODS

Six hundred and twenty one individuals considered to be at increased risk of coronary heart disease were randomised, following an 8 week placebo 'run in' period, to receive 40 mg daily simvastatin, 20 mg daily simvastatin, or matching placebo. Patients with a baseline corrected visual acuity better than 6/24 and without a history of cataract were eligible for detailed ophthalmic assessment at 6 months (539 patients assessed) and at 18 months (474 patients assessed).

RESULTS

No significant differences between the treatment groups were detected at the 6 month or 18 month visit in the refractive condition of the eye or in the mean intraocular pressure. Nor were there clear differences in the Oxford grading system scores for various measures of the major types of cataract (cortical spokes, posterior subcapsular cataract, nuclear brunescence, white scatter) or for other morphological features visible within the lens (fibre folds or focal dots). Scheimpflug slit image photographs and retroillumination analysis of the percentage of cataract within a defined region of the lens were also performed at each visit, with no clear differences observed between the treatment groups.

CONCLUSION

This single centre double blind study found no good evidence of any adverse effects of 18 months of simvastatin treatment on lens opacity formation, using a variety of validated techniques to assess cataract development. Routine clinic follow up of visual symptoms and admission to hospital for ophthalmic procedures over 5 years of treatment was also reassuring, with no excess adverse outcomes observed with simvastatin.

Study of nuclear cataract progression using the National Eye Institute Scheimpflug system

AIMS

A study was conducted to determine the capability of the recently developed National Eye Institute (NEI) Scheimpflug cataract imaging system in detecting changes in the nuclear region of the lens over a 1 year period.

METHODS

Twenty five eyes with pure nuclear cataracts with mean nuclear densities < or = 0.30 optical density units (ODU) as well as 30 normal control eyes were each examined at baseline and 12 months later. Computerised densitometry using the NEI Scheimpflug cataract imaging system was performed. Clinical grading of the lenses was also done using the Lens Opacities Classification System II (LOCS II). For densitometry, a change of plus or minus 0.023 ODU (the 99% range) in mean density in the nuclear area was considered a progression or regression at 1 year.

RESULTS

Using the Scheimpflug densitometry, 14 of the 25 cataractous eyes showed significant progression at 1 year. In the normal control group, only three of the 30 eyes showed significant progression. In contrast, using the LOCS II clinical grading, only two of the 25 cataractous eyes showed a one step increase, two of the 30 controls progressed at 1 year, and none regressed. There was no significant difference in visual acuity.

CONCLUSION

This study suggests the value of the NEI Scheimpflug cataract imaging system in detecting nuclear change within 1 year. However, clinically significant changes may require longer follow up periods. These data will be useful in planning future longitudinal studies of nuclear cataracts, such as for clinical trials of anticataract drugs.

Validation of methods for the assessment of cataract progression in the Roche European-American Anticataract Trial (REACT)

The Roche European-American Anticataract Trial (REACT) will assess the effect of antioxidants on progression of cataract in humans. This report evaluates the methods used in REACT. Seventy three subjects (139 eyes) with cortical (C), posterior subcapsular (P), nuclear (N) or mixed cataract were seen twice within two weeks for eye examinations, assessments of visual function, lens photographs and CCD images. The degree of cataract and nuclear color (NC) were assessed with subjective (LOCS III) and objective (computerized, CASE 2000 CCD) methods. Repeat visit values were used to calculate intraclass correlation coefficients (r1) and 95% tolerance limits (TL). A clinically significant change (CSC) was defined as one step in LOCS III. The relative power of each method to detect cataract change and sample sizes needed to achieve statistically significant results were calculated. The r1 values for visual function tests ranged from 0.76 to 0.88; if these tests of visual function were used to detect a clinically significant change in cataract severity, sample sizes of 840 to 2707 per group would be needed. The r1 values for LOCS III were 0.88 to 0.97, and sample sizes ranged from 50 to 135 per group. The r1 values for the CCD were 0.93 to 0.98, and sample sizes ranged from 1 to 42 with poorer values relating to measurement of P. We conclude that the methods used in REACT are reproducible. The analytical algorithms in the image analysis programs did not permit differentiation between C and P opacification; therefore, P cataract is best measured with LOCS III. REACT sample sizes are adequate to detect a difference of 0.2 LOCS III units/year between the mean rates of cataract progression in two groups.

Comparison of linear, multilinear and mask microdensitometric analyses of Scheimpflug images of the lens nucleus

We wanted to determine the agreement among three methods currently used to measure the average density of the nucleus from a Scheimpflug video image of the lens, namely, the multilinear, linear and mask techniques. Using the NEI Scheimpflug Cataract Imaging System, video images of the lens were obtained from 49 eyes of 31 consecutive patients with predominantly nuclear opacities of varying severities. For each image, 3 separate determinations of the average nuclear density [in optical density units (odu)] were obtained by one analyst sequentially applying each of the three methods. Repeat measurements were obtained by the same analyst one week apart to evaluate reproducibility (using 95% error range), of each of the methods. Pairwise comparisons of the 3 methods were also done. Only the error due to outlining of the nucleus was assessed. Reproducibility of each method was excellent. The 95% error ranges were +/- 0.015 odu for the linear, +/- 0.013 odu for the multilinear, and +/- 0.017 odu for the mask methods. Very strong linear relationships were observed between the linear and multilinear methods (R2 = 0.99), between the linear and mask methods (R2 = 0.97), and between the multilinear and mask methods (R2 = 0.98). Simple linear regressions calibrating these three methods against each other would facilitate comparison of density measurements using any of these methods for analysis of Scheimpflug images of the lens nucleus.

Spatial distribution of back scattering in the nuclear area of the non-cataractous human lens

The spatial distribution of back scattering from a vertical cross-section of the nuclear area in non-cataractous human lens was investigated. The cross-section was centred on the pupil. There is no significant difference in average nuclear back scattering between sides. The distribution of back scattering along an axis perpendicular to the anatomical axis can be modelled as a second-order polynomial. It is believed that the increase of back scattering in the central region corresponds to the peak protein concentration in the centre of the nucleus. This information was obtained by imaging back scattering with Scheimpflug photography. The back scattering was measured photometrically in a 3 x 10 matrix of measuring areas within the lens nucleus. Each measuring area was 0.20 x 0.20 mm in size. It is anticipated that the established model will allow detection of nuclear cataract with high sensitivity, especially in early stages.

Central corneal light scatter in long-term diabetics

Changes in corneal thickness have been correlated with severity of diabetic retinopathy. Measuring light scatter at the central cornea may reflect the changes in corneal thickness and hence the retinopathy. This study compared the peak central corneal light scatter between 22 insulin-dependent diabetic patients with disease of at least 10 years' duration and 29 controls. No significant difference was found in the light-scattering properties of the central cornea between the two groups. This technique does not offer an alternative method of screening for diabetic retinopathy.

Is cortical spoke cataract due to lens fibre breaks? The relationship between fibre folds, fibre breaks, waterclefts and spoke cataract

Fibre folds, previously called lamellar separation of the lens, have been found by electron microscopy to be associated with fibre breaks, which are seen in vivo as the circular shades of Obazawa. This led to the present study to determine the relationship between fibre folds, fibre breaks, waterclefts and spoke cataract. All lenses with fibre folds were found to have circular shades. A few instances of circular shades without fibre folds were found, suggesting that the fibre break may be the primary pathology. It was found that circular shades occurred in association with spoke cataract only when fibre folds were also present. Thus there is no essential causal relationship between fibre breaks and spoke cataract. The occurrence of waterclefts was unrelated to the presence of the other features. The lower nasal quadrant of the lens was the most common site for the four features. The depth of spoke cataracts was found to be unrelated to the age of the patient, which makes it unlikely that accommodational stress at the time of onset of presbyopia is causative.

The morphology of cataract and visual performance

The various effects of cataract on vision are reviewed. The morphological types of senile cataract are classified into three basic categories: cortical spoke, nuclear and posterior subcapsular (PSC). The significant basic effect of cataract on the optical system of the eye is that of light scattering. Forward light scattering (light scattered towards the retina) accounts for reduced contrast sensitivity, for glare and for reduced visual acuity. Other effects of cataract are a myopic shift, a possible astigmatism change, monocular diplopia and polyopia, colour vision shift, reduced light transmission, and field of vision reduction. The effect of the various cataract morphologies on these functions is discussed. The nature of the effect varies with the degree of the cataract and with the cataract morphology. The assessment of a patient's visual disability is therefore not a simple task and cannot be based solely on the visual acuity nor on the objective measurement of the cataract.